Research peptides are not approved prescriptions
Why research peptides are not approved prescriptions: trial safeguards, purity-report limits, regulatory stages and what to tell a care team.
Search explainers, questions, and medicine profiles.
Every published article, newest first. Reporting, explainers, and practical guides on weight and metabolic health.
Why research peptides are not approved prescriptions: trial safeguards, purity-report limits, regulatory stages and what to tell a care team.
Randomized trials and real-world studies answer different questions. Learn about confounding, routine data, discontinuation and useful comparison limits.
Prepare a nutrition appointment that connects health goals, food access, symptoms and follow-up, with questions that make advice usable.
Understand progressive overload as a gradual, reviewable increase in challenge, with technique, goals and recovery guiding the next step.
Learn what a US serving-size label means, scale the figures to your actual portion, and compare foods without treating reference values as personal targets.
Orlistat evidence and limitations: digestive mechanism, XENDOS results, gastrointestinal effects, vitamin absorption and important interactions.
Oral Wegovy in the EU progressed from a May recommendation to a July 2026 Commission decision. Read the current adult label and access limits.
A product-by-product comparison of meal timing, daily versus weekly routines, device needs and the limits of comparing weight-loss results.
Naltrexone-bupropion benefits and restrictions: COR-I evidence, opioid and seizure concerns, blood pressure, mood and EU long-term safety review.